✦ LIBER ✦

Chapter 4: Pre-clinical efficacy and complication data required to justify a clinical trial

✍ Scribed by David K. C. Cooper; Anna Casu

Book ID: 110905060
Publisher: John Wiley and Sons
Year: 2009
Tongue: English
Weight: 126 KB
Volume: 16
Category: Article
ISSN: 0908-665X
DOI: 10.1111/j.1399-3089.2009.00543.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Antiemetic efficacy of the neurokinin-1

Antiemetic efficacy of the neurokinin-1 antagonist, aprepitant, plus a 5HT3 antagonist and a corticosteroid in patients receiving anthracyclines or cyclophosphamide in addition to high-dose cisplatin : Analysis of combined data from two phase III randomized clinical trials

✍ Richard J. Gralla; Ronald de Wit; Jorn Herrstedt; Alexandra D. Carides; Juliana 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 106 KB

Long-Term Clinical and Economic Analysis

Long-Term Clinical and Economic Analysis of the Endeavor Drug-Eluting Stent Versus the Driver Bare-Metal Stent: 4-Year Results From the ENDEAVOR II Trial (Randomized Controlled Trial to Evaluate the Safety and Efficacy of the Medtronic AVE ABT-578 Eluting Driver Coronary Stent in De Novo Native Coronary Artery Lesions)

✍ Eric L. Eisenstein; William Wijns; Jean Fajadet; Laura Mauri; Rex Edwards; Patri 📂 Article 📅 2009 🏛 American College of Cardiology 🌐 English ⚖ 364 KB